Mounjaro jab trial for unemployed begins

A five-year trial is underway in Greater Manchester to see how weight loss injections like Tirzepatide (branded as Zepbound and Mounjaro) affect job prospects for those living with obesity. The jab helps suppress appetite by mimicking a hormone that induces feelings of fullness. With obesity-related illnesses costing the NHS a whopping £11 billion a year, this trial could have significant implications. You can catch the latest from BBC Radio Manchester on Sounds and engage with them on social media or send story ideas via WhatsApp.

Read the full article at BBC News